Roeland Nusse's most recent trade in Bio-Techne Corp was a trade of 3,511 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on Oct. 24, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bio-Techne | Roeland Nusse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2024 | 3,511 | 3,511 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne | Roeland Nusse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2024 | 1,462 | 44,559 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne | Roeland Nusse | Director | Sale of securities on an exchange or to another person at price $ 76.98 per share. | 07 Mar 2024 | 10,400 | 43,097 (0%) | 0% | 77.0 | 800,627 | Common Stock |
| Bio-Techne | Roeland Nusse | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Apr 2023 | 377 | 28,811 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne | Roeland Nusse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2022 | 865 | 865 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne | Roeland Nusse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2022 | 338 | 7,297 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne | Roeland Nusse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2021 | 633 | 633 | - | - | Stock Option (right to buy) | |
| Bio-Techne | Roeland Nusse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2021 | 194 | 6,959 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne | Roeland Nusse | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2021 | 4,000 | 0 | - | - | Stock Option (right to buy) | |
| Bio-Techne | Roeland Nusse | Director | Sale of securities on an exchange or to another person at price $ 481.52 per share. | 23 Aug 2021 | 4,000 | 6,765 (0%) | 0% | 481.5 | 1,926,065 | Common Stock |
| Bio-Techne | Roeland Nusse | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 70.35 per share. | 23 Aug 2021 | 4,000 | 10,765 (0%) | 0% | 70.4 | 281,400 | Common Stock |
| Bio-Techne | Roeland Nusse | Director | Sale of securities on an exchange or to another person at price $ 385.08 per share. | 08 Feb 2021 | 6,000 | 6,765 (0%) | 0% | 385.1 | 2,310,481 | Common Stock |
| Bio-Techne | Roeland Nusse | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2021 | 5,000 | 0 | - | - | Stock Option (right to buy) | |
| Bio-Techne | Roeland Nusse | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.90 per share. | 08 Feb 2021 | 5,000 | 12,765 (0%) | 0% | 66.9 | 334,500 | Common Stock |
| Bio-Techne | Roeland Nusse | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2021 | 1,000 | 4,000 | - | - | Stock Option (right to buy) | |
| Bio-Techne | Roeland Nusse | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 70.35 per share. | 08 Feb 2021 | 1,000 | 7,765 (0%) | 0% | 70.4 | 70,350 | Common Stock |
| Bio-Techne | Roeland Nusse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2020 | 1,507 | 1,507 | - | - | Stock Option (Right to Buy) | |
| Bio-Techne | Roeland Nusse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2020 | 391 | 12,765 (0%) | 0% | 0 | Common Stock |